Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveAstraZeneca Says FDA Approves Drug For Rare Kidney Disease In Adults

Live News REGULATION FLASH L impact Oct 21, 2026, 11:07 PM UTC

AstraZeneca Says FDA Approves Drug For Rare Kidney Disease In Adults

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Uganda Central Bank Sells Foreign Currency After Rate Hike The Bank of Uganda said it was selling an undisclosed amount of foreign currency after a rate hike failed to stem shilling losses. M impact | REGULATION | Oct 22, 2026, 08:21 AM UTC Japan to Consider Reintroducing Gas and Electricity Subsidies Two government sources said Japan’s government will consider restoring the subsidies in December. The measures expired in September and would aim to cushion households from rising L impact | REGULATION | Oct 22, 2026, 08:11 AM UTC BIT Asset Management Wins FINMA Approval for Spot Bitcoin ETF The Swiss regulator approved the fund, which invests directly in bitcoin and is approved for retail investors in Switzerland. M impact | REGULATION | Oct 22, 2026, 06:52 AM UTC BaFin Revokes Bank Saderat Iran Hamburg License, Orders Liquidation Germany’s financial regulator said it revoked the bank’s Hamburg branch license and ordered its liquidation following sanctions. M impact | REGULATION | Oct 22, 2026, 05:30 AM UTC Review Finds KPMG Australia Mishandled Whistleblower Claims; Work Pause Extended A probe found KPMG Australia mishandled whistleblower allegations about client data leaks and allowed cultural and governance weaknesses to persist for years. It did not recommend L impact | REGULATION | Oct 22, 2026, 05:14 AM UTC India Food Regulator Seeks Evidence for Nestlé, Zydus Product Claims India’s food regulator issued notices to Nestlé India and Zydus Wellness, seeking scientific evidence for claims involving infant formula and Complan products. M impact | REGULATION | Oct 22, 2026, 05:01 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.